Document is current
Any future updates will be listed below
-
Authors
Kuburas, Adisa
Russo, Andrew F.
-
Funding
Funding for this research was provided by:
NIH (RF1 NS113839; R01 NS075599)
Iowa City Veterans Affairs Medical Center (I01 RX003523-01)
- License Information
-
More Information
Article History
Received: 20 January 2023
Accepted: 23 March 2023
First Online: 3 April 2023
Declarations
:
: Not applicable.
: Not applicable.
: AFR is a consultant for Lundbeck, Abbvie, Eli Lilly, and Schedule One Therapeutics. AK declares no competing interests.
